Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
APPLICATION OF CLEC-2 IN PREPARATION OF DRUG FOR TREATING CRANIOCEREBRAL INJURY
Document Type and Number:
WIPO Patent Application WO/2019/184002
Kind Code:
A1
Abstract:
Provided is an application of C-type lectin receptor-2 in the preparation of a drug for treating a craniocerebral injury. Also provided is a drug for treating a craniocerebral injury, comprising C-type lectin receptor-2 and a pharmaceutical acceptable excipient.

Inventors:
TAO LUYANG (CN)
GAO CHENG (CN)
CHEN XIPING (CN)
WANG HAOCHEN (CN)
LIU SINAN (CN)
TAO HONGXUN (CN)
Application Number:
PCT/CN2018/082109
Publication Date:
October 03, 2019
Filing Date:
April 08, 2018
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV SOOCHOW (CN)
International Classes:
A61K38/17; A61P25/00; A61P29/00
Domestic Patent References:
WO2008134445A22008-11-06
WO2014043334A12014-03-20
Other References:
KATE L. LOWE: "Podoplanin and CLEC-2 drive cerebrovascular patterning and integrity during development", BLOOD, vol. 125, no. 24, 11 June 2015 (2015-06-11), pages 3769 - 3777
HANG, QINGLEI ET AL.: "CLEC-2 (The Expression Significance of CLEC-2 in Inflammation of CNS)", JOURNAL OF NANTONG UNIVERSITY (MEDICAL SCIENCES), vol. 33, no. 1, 31 December 2012 (2012-12-31), pages 1 - 5
Attorney, Agent or Firm:
CENTRAL SOUTH WELL INTELLECTUAL PROPERTY OFFICE (CN)
Download PDF: